Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and appalachian adults who smoke cigarettes: a randomized cross‐over study
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Keller‐hamilton (2023)
Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Keyser (2023)
Tracing the movement of electronic cigarette flavor chemicals and nicotine from refill fluids to aerosol, lungs, exhale, and the environment.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Khachatoorian (2022)
association between e-cigarette use and sleep deprivation in U.S. Young adults: Results from the 2017 and 2018 Behavioral Risk Factor Surveillance System.
Individual Clinical
Safety
Adverse Effects
Kianersi (2021)
Daily Cigarette Consumption and Urine Cotinine Level between Dual Users of Electronic and Conventional Cigarettes, and Cigarette-Only Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Kim (2020)
association between electronic cigarette use and metabolic syndrome in the Korean general population: a nationwide population-based study.
Individual Clinical
Safety
Adverse Effects
Kim (2020)
association of electronic cigarette exposure with serum uric acid level and hyperuricemia: 2016-2017 Korea National health and Nutritional Examination Survey.
Individual Clinical
Safety
Adverse Effects
Kim (2021)
Changes in puffing topography and subjective effects over a 2-week period in e-cigarette naïve smokers: Effects of device type and nicotine concentrations.
Individual Clinical
User Topography
Kimber (2021)
Comparing the Effects of the EU- Versus the US-JUUL Pod in a Sample of UK Smokers: Nicotine absorption, Satisfaction, and Other Nicotine-Related Subjective Effects.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Kimber (2023)